J. Leadbetter

Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study.

P. Flume, C. Daines, M. Aitken, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Cost Effectiveness of Inhaled Mannitol (Bronchitol®) in Patients with Cystic Fibrosis

M. Schwenkglenks, J. Leadbetter, E. Warren, 2019, PharmacoEconomics.

The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations

C. Porsbjerg, A. Sverrild, J. Leadbetter, 2021, Respiratory Research.

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

L. Lands, H. Tiddens, K. De Boeck, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

C. Arango-Dávila, M. Dossenbach, J. Leadbetter, 2005, The Journal of clinical psychiatry.

Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol

M. Ranson, H. Swaisland, M. Wild, 2005, Clinical pharmacokinetics.

Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)

P. Marlton, A. Roberts, A. Wei, 2020 .

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

P. Marlton, A. Roberts, A. Wei, 2023, Blood.